Print

BioMarin Pharmaceutical Inc. (BMRN) to Present at the Canaccord Genuity Growth Conference  
8/9/2012 9:18:45 AM

NOVATO, Calif., Aug. 9, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Dan Spiegelman, Chief Financial Officer at BioMarin, will present a company update at the Canaccord Genuity Growth Conference in Boston on Wednesday, August 15, 2012 at 1:00 p.m. EDT.
//-->